These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12200905)

  • 1. Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study.
    Cobanoğlu N; Ozçelik U; Göçmen A; Kiper N; Doğru D
    Acta Paediatr; 2002; 91(7):793-8. PubMed ID: 12200905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
    Rust P; Eichler I; Renner S; Elmadfa I
    Int J Vitam Nutr Res; 1998; 68(2):83-7. PubMed ID: 9565821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
    Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
    Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function.
    Rust P; Eichler I; Renner S; Elmadfa I
    Ann Nutr Metab; 2000; 44(1):30-7. PubMed ID: 10838464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotenoid levels in normal children and in children with cystic fibrosis.
    Homnick DN; Cox JH; DeLoof MJ; Ringer TV
    J Pediatr; 1993 May; 122(5 Pt 1):703-7. PubMed ID: 8496746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis.
    Lepage G; Champagne J; Ronco N; Lamarre A; Osberg I; Sokol RJ; Roy CC
    Am J Clin Nutr; 1996 Jul; 64(1):87-93. PubMed ID: 8669420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis.
    Renner S; Rath R; Rust P; Lehr S; Frischer T; Elmadfa I; Eichler I
    Thorax; 2001 Jan; 56(1):48-52. PubMed ID: 11120904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis.
    Papas KA; Sontag MK; Pardee C; Sokol RJ; Sagel SD; Accurso FJ; Wagener JS
    J Cyst Fibros; 2008 Jan; 7(1):60-7. PubMed ID: 17569601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency].
    Laskowska-Klita T; Chełchowska M
    Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with red palm oil increases β-carotene and vitamin A blood levels in patients with cystic fibrosis.
    Sommerburg O; De Spirt S; Mattern A; Joachim C; Langhans CD; Nesaretnam K; Siems W; Stahl W; Mall MA
    Mediators Inflamm; 2015; 2015():817127. PubMed ID: 25688177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
    Wood LG; Fitzgerald DA; Lee AK; Garg ML
    Am J Clin Nutr; 2003 Jan; 77(1):150-9. PubMed ID: 12499335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant micronutrients for lung disease in cystic fibrosis.
    Shamseer L; Adams D; Brown N; Johnson JA; Vohra S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007020. PubMed ID: 21154377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study.
    Winklhofer-Roob BM; van't Hof MA; Shmerling DH
    Acta Paediatr; 1995 Oct; 84(10):1132-6. PubMed ID: 8563224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.
    Collins CE; Quaggiotto P; Wood L; O'Loughlin EV; Henry RL; Garg ML
    Lipids; 1999 Jun; 34(6):551-6. PubMed ID: 10405967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation and antioxidant defenses in cystic fibrosis patients.
    Benabdeslam H; Abidi H; Garcia I; Bellon G; Gilly R; Revol A
    Clin Chem Lab Med; 1999 May; 37(5):511-6. PubMed ID: 10418740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma carotenoids in German children and adolescents.
    Lenhartz H; Schweitzer R; Bötticher D; Leichsenring M
    Eur J Pediatr; 1997 Jan; 156(1):71-3. PubMed ID: 9007497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant status in patients with cystic fibrosis.
    Madarasi A; Lugassi A; Greiner E; Holics K; Biró L; Mozsáry E
    Ann Nutr Metab; 2000; 44(5-6):207-11. PubMed ID: 11146325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis.
    Homnick DN; Spillers CR; Cox SR; Cox JH; Yelton LA; DeLoof MJ; Oliver LK; Ringer TV
    J Pediatr; 1995 Sep; 127(3):491-4. PubMed ID: 7658286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.